nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextromethorphan—CYP2C8—Tazarotene—psoriasis	0.0606	0.0727	CbGbCtD
Dextromethorphan—CYP3A5—Beclomethasone—psoriasis	0.0586	0.0703	CbGbCtD
Dextromethorphan—CYP2B6—Cholecalciferol—psoriasis	0.0341	0.041	CbGbCtD
Dextromethorphan—CYP2D6—Hydroxyurea—psoriasis	0.0272	0.0327	CbGbCtD
Dextromethorphan—CYP2C8—Cholecalciferol—psoriasis	0.0259	0.031	CbGbCtD
Dextromethorphan—CYP3A7—Hydrocortisone—psoriasis	0.0249	0.0299	CbGbCtD
Dextromethorphan—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0249	0.0299	CbGbCtD
Dextromethorphan—CYP3A7—Cyclosporine—psoriasis	0.0236	0.0283	CbGbCtD
Dextromethorphan—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0236	0.0283	CbGbCtD
Dextromethorphan—CYP3A5—Mycophenolate mofetil—psoriasis	0.0233	0.028	CbGbCtD
Dextromethorphan—CYP2C8—Mycophenolate mofetil—psoriasis	0.0224	0.0269	CbGbCtD
Dextromethorphan—CYP2C19—Cholecalciferol—psoriasis	0.0217	0.026	CbGbCtD
Dextromethorphan—CYP3A4—Calcitriol—psoriasis	0.0204	0.0244	CbGbCtD
Dextromethorphan—CYP3A5—Hydrocortisone—psoriasis	0.0187	0.0225	CbGbCtD
Dextromethorphan—CYP2C9—Cholecalciferol—psoriasis	0.018	0.0216	CbGbCtD
Dextromethorphan—CYP2C8—Hydrocortisone—psoriasis	0.018	0.0216	CbGbCtD
Dextromethorphan—CYP3A5—Cyclosporine—psoriasis	0.0177	0.0212	CbGbCtD
Dextromethorphan—CYP2C8—Cyclosporine—psoriasis	0.017	0.0204	CbGbCtD
Dextromethorphan—CYP2D6—Cholecalciferol—psoriasis	0.0165	0.0198	CbGbCtD
Dextromethorphan—CYP3A4—Methoxsalen—psoriasis	0.0158	0.019	CbGbCtD
Dextromethorphan—CYP3A7—Dexamethasone—psoriasis	0.0155	0.0186	CbGbCtD
Dextromethorphan—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.0155	0.0186	CbGbCtD
Dextromethorphan—ABCB1—Mycophenolate mofetil—psoriasis	0.0152	0.0182	CbGbCtD
Dextromethorphan—CYP2C19—Prednisone—psoriasis	0.015	0.018	CbGbCtD
Dextromethorphan—CYP2E1—Dexamethasone—psoriasis	0.015	0.018	CbGbCtD
Dextromethorphan—CYP2B6—Dexamethasone—psoriasis	0.0148	0.0177	CbGbCtD
Dextromethorphan—CYP2C19—Cyclosporine—psoriasis	0.0143	0.0171	CbGbCtD
Dextromethorphan—ABCB1—Betamethasone—psoriasis	0.013	0.0156	CbGbCtD
Dextromethorphan—ABCB1—Prednisolone—psoriasis	0.0128	0.0154	CbGbCtD
Dextromethorphan—ABCB1—Hydrocortisone—psoriasis	0.0122	0.0146	CbGbCtD
Dextromethorphan—ABCB1—Prednisone—psoriasis	0.0121	0.0146	CbGbCtD
Dextromethorphan—CYP2C9—Cyclosporine—psoriasis	0.0119	0.0142	CbGbCtD
Dextromethorphan—CYP3A5—Dexamethasone—psoriasis	0.0116	0.014	CbGbCtD
Dextromethorphan—ABCB1—Cyclosporine—psoriasis	0.0115	0.0138	CbGbCtD
Dextromethorphan—CYP2C8—Dexamethasone—psoriasis	0.0112	0.0134	CbGbCtD
Dextromethorphan—CYP2D6—Cyclosporine—psoriasis	0.0108	0.013	CbGbCtD
Dextromethorphan—CYP3A4—Cholecalciferol—psoriasis	0.0105	0.0126	CbGbCtD
Dextromethorphan—CYP2C19—Dexamethasone—psoriasis	0.00939	0.0113	CbGbCtD
Dextromethorphan—CYP3A4—Mycophenolate mofetil—psoriasis	0.00909	0.0109	CbGbCtD
Dextromethorphan—CYP3A4—Triamcinolone—psoriasis	0.00909	0.0109	CbGbCtD
Dextromethorphan—CYP2C9—Dexamethasone—psoriasis	0.0078	0.00936	CbGbCtD
Dextromethorphan—CYP3A4—Betamethasone—psoriasis	0.0078	0.00936	CbGbCtD
Dextromethorphan—CYP3A4—Prednisolone—psoriasis	0.0077	0.00923	CbGbCtD
Dextromethorphan—ABCB1—Dexamethasone—psoriasis	0.00757	0.00909	CbGbCtD
Dextromethorphan—CYP3A4—Hydrocortisone—psoriasis	0.0073	0.00875	CbGbCtD
Dextromethorphan—CYP3A4—Prednisone—psoriasis	0.00727	0.00872	CbGbCtD
Dextromethorphan—CYP2D6—Dexamethasone—psoriasis	0.00714	0.00856	CbGbCtD
Dextromethorphan—CYP3A4—Cyclosporine—psoriasis	0.00689	0.00827	CbGbCtD
Dextromethorphan—ABCB1—Methotrexate—psoriasis	0.00609	0.0073	CbGbCtD
Dextromethorphan—CYP3A4—Dexamethasone—psoriasis	0.00454	0.00544	CbGbCtD
Dextromethorphan—Digestion impaired—Methoxsalen—psoriasis	0.00367	0.035	CcSEcCtD
Dextromethorphan—Digestion impaired—Hydroxyurea—psoriasis	0.00228	0.0218	CcSEcCtD
Dextromethorphan—Psychotic disorder—Calcitriol—psoriasis	0.00155	0.0148	CcSEcCtD
Dextromethorphan—Digestion impaired—Cyclosporine—psoriasis	0.00155	0.0148	CcSEcCtD
Dextromethorphan—Hypersensitivity—Calcipotriol—psoriasis	0.00145	0.0138	CcSEcCtD
Dextromethorphan—Hypoglycaemia—Fluocinolone Acetonide—psoriasis	0.00144	0.0138	CcSEcCtD
Dextromethorphan—Immune system disorder—Fluocinonide—psoriasis	0.00141	0.0134	CcSEcCtD
Dextromethorphan—Drowsiness—Calcitriol—psoriasis	0.00122	0.0117	CcSEcCtD
Dextromethorphan—Nervous system disorder—Fluocinonide—psoriasis	0.00109	0.0104	CcSEcCtD
Dextromethorphan—Tension—Methoxsalen—psoriasis	0.00105	0.01	CcSEcCtD
Dextromethorphan—Nervousness—Methoxsalen—psoriasis	0.00104	0.00993	CcSEcCtD
Dextromethorphan—Hypoglycaemia—Mycophenolic acid—psoriasis	0.000951	0.00907	CcSEcCtD
Dextromethorphan—SIGMAR1—Levonorgestrel—Hydrocortisone—psoriasis	0.000907	1	CbGdCrCtD
Dextromethorphan—Psychotic disorder—Mycophenolic acid—psoriasis	0.000906	0.00865	CcSEcCtD
Dextromethorphan—Hypersensitivity—Clobetasol propionate—psoriasis	0.000905	0.00864	CcSEcCtD
Dextromethorphan—Immune system disorder—Acitretin—psoriasis	0.000882	0.00841	CcSEcCtD
Dextromethorphan—Agitation—Calcitriol—psoriasis	0.000878	0.00837	CcSEcCtD
Dextromethorphan—Drowsiness—Hydroxyurea—psoriasis	0.000854	0.00814	CcSEcCtD
Dextromethorphan—Mental disorder—Fluocinolone Acetonide—psoriasis	0.000853	0.00814	CcSEcCtD
Dextromethorphan—Tension—Acitretin—psoriasis	0.000834	0.00796	CcSEcCtD
Dextromethorphan—Nervousness—Acitretin—psoriasis	0.000825	0.00787	CcSEcCtD
Dextromethorphan—Hypersensitivity—Fluocinonide—psoriasis	0.000816	0.00779	CcSEcCtD
Dextromethorphan—Dyspepsia—Methoxsalen—psoriasis	0.00077	0.00735	CcSEcCtD
Dextromethorphan—Hypoglycaemia—Cyclosporine—psoriasis	0.000769	0.00734	CcSEcCtD
Dextromethorphan—Hallucination—Hydroxyurea—psoriasis	0.000762	0.00728	CcSEcCtD
Dextromethorphan—Gastrointestinal disorder—Methoxsalen—psoriasis	0.000755	0.0072	CcSEcCtD
Dextromethorphan—Hypoglycaemia—Mycophenolate mofetil—psoriasis	0.00075	0.00716	CcSEcCtD
Dextromethorphan—Dizziness—Beclomethasone—psoriasis	0.000739	0.00706	CcSEcCtD
Dextromethorphan—Dizziness—Fluocinonide—psoriasis	0.000733	0.00699	CcSEcCtD
Dextromethorphan—Feeling abnormal—Methoxsalen—psoriasis	0.000721	0.00688	CcSEcCtD
Dextromethorphan—Psychotic disorder—Mycophenolate mofetil—psoriasis	0.000715	0.00682	CcSEcCtD
Dextromethorphan—Somnolence—Calcitriol—psoriasis	0.000693	0.00661	CcSEcCtD
Dextromethorphan—Nervous system disorder—Fluocinolone Acetonide—psoriasis	0.000678	0.00647	CcSEcCtD
Dextromethorphan—Constipation—Calcitriol—psoriasis	0.000667	0.00636	CcSEcCtD
Dextromethorphan—Nausea—Beclomethasone—psoriasis	0.000664	0.00634	CcSEcCtD
Dextromethorphan—Psychotic disorder—Hydrocortisone—psoriasis	0.000651	0.00622	CcSEcCtD
Dextromethorphan—Hypersensitivity—Methoxsalen—psoriasis	0.000644	0.00615	CcSEcCtD
Dextromethorphan—Hallucination—Mycophenolic acid—psoriasis	0.000639	0.00609	CcSEcCtD
Dextromethorphan—Gastrointestinal pain—Calcitriol—psoriasis	0.000637	0.00608	CcSEcCtD
Dextromethorphan—Irritability—Hydrocortisone—psoriasis	0.000637	0.00607	CcSEcCtD
Dextromethorphan—Abdominal discomfort—Cyclosporine—psoriasis	0.000622	0.00593	CcSEcCtD
Dextromethorphan—Somnolence—Acitretin—psoriasis	0.000616	0.00588	CcSEcCtD
Dextromethorphan—Abdominal pain—Calcitriol—psoriasis	0.000616	0.00588	CcSEcCtD
Dextromethorphan—Dyspepsia—Acitretin—psoriasis	0.00061	0.00582	CcSEcCtD
Dextromethorphan—Gastrointestinal disorder—Acitretin—psoriasis	0.000599	0.00571	CcSEcCtD
Dextromethorphan—Fatigue—Acitretin—psoriasis	0.000598	0.0057	CcSEcCtD
Dextromethorphan—Gastrointestinal disorder—Fluocinolone Acetonide—psoriasis	0.000597	0.0057	CcSEcCtD
Dextromethorphan—Constipation—Acitretin—psoriasis	0.000593	0.00566	CcSEcCtD
Dextromethorphan—Dizziness—Methoxsalen—psoriasis	0.000578	0.00552	CcSEcCtD
Dextromethorphan—Hypersensitivity—Calcitriol—psoriasis	0.000574	0.00548	CcSEcCtD
Dextromethorphan—Feeling abnormal—Acitretin—psoriasis	0.000571	0.00545	CcSEcCtD
Dextromethorphan—Gastrointestinal pain—Acitretin—psoriasis	0.000567	0.00541	CcSEcCtD
Dextromethorphan—Mental disorder—Mycophenolic acid—psoriasis	0.000562	0.00537	CcSEcCtD
Dextromethorphan—Asthenia—Calcitriol—psoriasis	0.000559	0.00534	CcSEcCtD
Dextromethorphan—Psychotic disorder—Betamethasone—psoriasis	0.000557	0.00531	CcSEcCtD
Dextromethorphan—Psychotic disorder—Dexamethasone—psoriasis	0.000557	0.00531	CcSEcCtD
Dextromethorphan—Tension—Mycophenolic acid—psoriasis	0.000548	0.00523	CcSEcCtD
Dextromethorphan—Abdominal pain—Acitretin—psoriasis	0.000548	0.00523	CcSEcCtD
Dextromethorphan—Irritability—Betamethasone—psoriasis	0.000544	0.00519	CcSEcCtD
Dextromethorphan—Irritability—Dexamethasone—psoriasis	0.000544	0.00519	CcSEcCtD
Dextromethorphan—Nervousness—Mycophenolic acid—psoriasis	0.000543	0.00518	CcSEcCtD
Dextromethorphan—Nervous system disorder—Hydroxyurea—psoriasis	0.000534	0.00509	CcSEcCtD
Dextromethorphan—Diarrhoea—Calcitriol—psoriasis	0.000533	0.00509	CcSEcCtD
Dextromethorphan—Nausea—Methoxsalen—psoriasis	0.000519	0.00496	CcSEcCtD
Dextromethorphan—Agitation—Mycophenolic acid—psoriasis	0.000513	0.0049	CcSEcCtD
Dextromethorphan—Hypersensitivity—Acitretin—psoriasis	0.000511	0.00487	CcSEcCtD
Dextromethorphan—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.000509	0.00486	CcSEcCtD
Dextromethorphan—Hallucination—Mycophenolate mofetil—psoriasis	0.000504	0.00481	CcSEcCtD
Dextromethorphan—Asthenia—Acitretin—psoriasis	0.000498	0.00475	CcSEcCtD
Dextromethorphan—Vomiting—Calcitriol—psoriasis	0.000496	0.00473	CcSEcCtD
Dextromethorphan—Psychotic disorder—Prednisone—psoriasis	0.000485	0.00462	CcSEcCtD
Dextromethorphan—Somnolence—Hydroxyurea—psoriasis	0.000484	0.00462	CcSEcCtD
Dextromethorphan—Dyspepsia—Hydroxyurea—psoriasis	0.000479	0.00457	CcSEcCtD
Dextromethorphan—Diarrhoea—Acitretin—psoriasis	0.000474	0.00453	CcSEcCtD
Dextromethorphan—Irritability—Prednisone—psoriasis	0.000474	0.00452	CcSEcCtD
Dextromethorphan—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.000473	0.00451	CcSEcCtD
Dextromethorphan—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.00047	0.00448	CcSEcCtD
Dextromethorphan—Fatigue—Hydroxyurea—psoriasis	0.000469	0.00448	CcSEcCtD
Dextromethorphan—Constipation—Hydroxyurea—psoriasis	0.000466	0.00444	CcSEcCtD
Dextromethorphan—Nausea—Calcitriol—psoriasis	0.000463	0.00442	CcSEcCtD
Dextromethorphan—Confusional state—Mycophenolic acid—psoriasis	0.00046	0.00439	CcSEcCtD
Dextromethorphan—Hallucination—Hydrocortisone—psoriasis	0.000459	0.00438	CcSEcCtD
Dextromethorphan—Dizziness—Acitretin—psoriasis	0.000459	0.00438	CcSEcCtD
Dextromethorphan—Dizziness—Fluocinolone Acetonide—psoriasis	0.000457	0.00436	CcSEcCtD
Dextromethorphan—Mental disorder—Cyclosporine—psoriasis	0.000455	0.00434	CcSEcCtD
Dextromethorphan—Feeling abnormal—Hydroxyurea—psoriasis	0.000449	0.00428	CcSEcCtD
Dextromethorphan—Nervous system disorder—Mycophenolic acid—psoriasis	0.000447	0.00427	CcSEcCtD
Dextromethorphan—Mental disorder—Mycophenolate mofetil—psoriasis	0.000444	0.00423	CcSEcCtD
Dextromethorphan—Tension—Cyclosporine—psoriasis	0.000444	0.00423	CcSEcCtD
Dextromethorphan—Vomiting—Acitretin—psoriasis	0.000441	0.00421	CcSEcCtD
Dextromethorphan—Vomiting—Fluocinolone Acetonide—psoriasis	0.00044	0.0042	CcSEcCtD
Dextromethorphan—Nervousness—Cyclosporine—psoriasis	0.000439	0.00419	CcSEcCtD
Dextromethorphan—Tension—Mycophenolate mofetil—psoriasis	0.000433	0.00413	CcSEcCtD
Dextromethorphan—Nervousness—Mycophenolate mofetil—psoriasis	0.000428	0.00409	CcSEcCtD
Dextromethorphan—Immune system disorder—Hydrocortisone—psoriasis	0.000417	0.00398	CcSEcCtD
Dextromethorphan—Agitation—Cyclosporine—psoriasis	0.000415	0.00396	CcSEcCtD
Dextromethorphan—Nausea—Acitretin—psoriasis	0.000412	0.00393	CcSEcCtD
Dextromethorphan—Nausea—Fluocinolone Acetonide—psoriasis	0.000411	0.00392	CcSEcCtD
Dextromethorphan—Somnolence—Mycophenolic acid—psoriasis	0.000405	0.00387	CcSEcCtD
Dextromethorphan—Agitation—Mycophenolate mofetil—psoriasis	0.000405	0.00387	CcSEcCtD
Dextromethorphan—Mental disorder—Hydrocortisone—psoriasis	0.000404	0.00386	CcSEcCtD
Dextromethorphan—Dyspepsia—Mycophenolic acid—psoriasis	0.000401	0.00383	CcSEcCtD
Dextromethorphan—Hypersensitivity—Hydroxyurea—psoriasis	0.000401	0.00383	CcSEcCtD
Dextromethorphan—Irritability—Methotrexate—psoriasis	0.000396	0.00378	CcSEcCtD
Dextromethorphan—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000394	0.00376	CcSEcCtD
Dextromethorphan—Fatigue—Mycophenolic acid—psoriasis	0.000393	0.00375	CcSEcCtD
Dextromethorphan—Hallucination—Dexamethasone—psoriasis	0.000392	0.00374	CcSEcCtD
Dextromethorphan—Hallucination—Betamethasone—psoriasis	0.000392	0.00374	CcSEcCtD
Dextromethorphan—Asthenia—Hydroxyurea—psoriasis	0.000391	0.00373	CcSEcCtD
Dextromethorphan—Constipation—Mycophenolic acid—psoriasis	0.00039	0.00372	CcSEcCtD
Dextromethorphan—Feeling abnormal—Mycophenolic acid—psoriasis	0.000376	0.00359	CcSEcCtD
Dextromethorphan—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000373	0.00356	CcSEcCtD
Dextromethorphan—Diarrhoea—Hydroxyurea—psoriasis	0.000372	0.00355	CcSEcCtD
Dextromethorphan—Confusional state—Cyclosporine—psoriasis	0.000372	0.00355	CcSEcCtD
Dextromethorphan—Confusional state—Mycophenolate mofetil—psoriasis	0.000363	0.00346	CcSEcCtD
Dextromethorphan—Nervous system disorder—Cyclosporine—psoriasis	0.000362	0.00345	CcSEcCtD
Dextromethorphan—Abdominal pain—Mycophenolic acid—psoriasis	0.00036	0.00344	CcSEcCtD
Dextromethorphan—Dizziness—Hydroxyurea—psoriasis	0.00036	0.00344	CcSEcCtD
Dextromethorphan—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000353	0.00337	CcSEcCtD
Dextromethorphan—Vomiting—Hydroxyurea—psoriasis	0.000346	0.0033	CcSEcCtD
Dextromethorphan—Abdominal discomfort—Methotrexate—psoriasis	0.000344	0.00328	CcSEcCtD
Dextromethorphan—Hallucination—Prednisone—psoriasis	0.000342	0.00326	CcSEcCtD
Dextromethorphan—Somnolence—Cyclosporine—psoriasis	0.000328	0.00313	CcSEcCtD
Dextromethorphan—Asthenia—Mycophenolic acid—psoriasis	0.000327	0.00312	CcSEcCtD
Dextromethorphan—Dyspepsia—Cyclosporine—psoriasis	0.000325	0.0031	CcSEcCtD
Dextromethorphan—Nausea—Hydroxyurea—psoriasis	0.000323	0.00309	CcSEcCtD
Dextromethorphan—Nervous system disorder—Hydrocortisone—psoriasis	0.000321	0.00307	CcSEcCtD
Dextromethorphan—Somnolence—Mycophenolate mofetil—psoriasis	0.00032	0.00305	CcSEcCtD
Dextromethorphan—Drowsiness—Methotrexate—psoriasis	0.00032	0.00305	CcSEcCtD
Dextromethorphan—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000318	0.00304	CcSEcCtD
Dextromethorphan—Fatigue—Cyclosporine—psoriasis	0.000318	0.00303	CcSEcCtD
Dextromethorphan—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000317	0.00302	CcSEcCtD
Dextromethorphan—Constipation—Cyclosporine—psoriasis	0.000315	0.00301	CcSEcCtD
Dextromethorphan—Diarrhoea—Mycophenolic acid—psoriasis	0.000312	0.00298	CcSEcCtD
Dextromethorphan—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000311	0.00296	CcSEcCtD
Dextromethorphan—Immune system disorder—Prednisone—psoriasis	0.00031	0.00296	CcSEcCtD
Dextromethorphan—Constipation—Mycophenolate mofetil—psoriasis	0.000308	0.00294	CcSEcCtD
Dextromethorphan—Feeling abnormal—Cyclosporine—psoriasis	0.000304	0.0029	CcSEcCtD
Dextromethorphan—Gastrointestinal pain—Cyclosporine—psoriasis	0.000302	0.00288	CcSEcCtD
Dextromethorphan—Dizziness—Mycophenolic acid—psoriasis	0.000302	0.00288	CcSEcCtD
Dextromethorphan—Mental disorder—Prednisone—psoriasis	0.000301	0.00287	CcSEcCtD
Dextromethorphan—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000297	0.00283	CcSEcCtD
Dextromethorphan—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000294	0.00281	CcSEcCtD
Dextromethorphan—Abdominal pain—Cyclosporine—psoriasis	0.000292	0.00278	CcSEcCtD
Dextromethorphan—Vomiting—Mycophenolic acid—psoriasis	0.00029	0.00277	CcSEcCtD
Dextromethorphan—Dyspepsia—Hydrocortisone—psoriasis	0.000289	0.00275	CcSEcCtD
Dextromethorphan—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000284	0.00271	CcSEcCtD
Dextromethorphan—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000283	0.0027	CcSEcCtD
Dextromethorphan—Fatigue—Hydrocortisone—psoriasis	0.000283	0.0027	CcSEcCtD
Dextromethorphan—Feeling abnormal—Prednisolone—psoriasis	0.000277	0.00264	CcSEcCtD
Dextromethorphan—Nervous system disorder—Dexamethasone—psoriasis	0.000275	0.00262	CcSEcCtD
Dextromethorphan—Nervous system disorder—Betamethasone—psoriasis	0.000275	0.00262	CcSEcCtD
Dextromethorphan—Agitation—Prednisone—psoriasis	0.000275	0.00262	CcSEcCtD
Dextromethorphan—Hypersensitivity—Cyclosporine—psoriasis	0.000272	0.00259	CcSEcCtD
Dextromethorphan—Dyspepsia—Triamcinolone—psoriasis	0.000272	0.00259	CcSEcCtD
Dextromethorphan—Nausea—Mycophenolic acid—psoriasis	0.000271	0.00258	CcSEcCtD
Dextromethorphan—Feeling abnormal—Hydrocortisone—psoriasis	0.00027	0.00258	CcSEcCtD
Dextromethorphan—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000268	0.00256	CcSEcCtD
Dextromethorphan—Fatigue—Triamcinolone—psoriasis	0.000266	0.00254	CcSEcCtD
Dextromethorphan—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000265	0.00253	CcSEcCtD
Dextromethorphan—Asthenia—Cyclosporine—psoriasis	0.000265	0.00253	CcSEcCtD
Dextromethorphan—Immune system disorder—Methotrexate—psoriasis	0.000259	0.00247	CcSEcCtD
Dextromethorphan—Abdominal pain—Hydrocortisone—psoriasis	0.000259	0.00247	CcSEcCtD
Dextromethorphan—Asthenia—Mycophenolate mofetil—psoriasis	0.000258	0.00246	CcSEcCtD
Dextromethorphan—Feeling abnormal—Triamcinolone—psoriasis	0.000254	0.00243	CcSEcCtD
Dextromethorphan—Diarrhoea—Cyclosporine—psoriasis	0.000252	0.00241	CcSEcCtD
Dextromethorphan—Mental disorder—Methotrexate—psoriasis	0.000251	0.0024	CcSEcCtD
Dextromethorphan—Hypersensitivity—Prednisolone—psoriasis	0.000247	0.00236	CcSEcCtD
Dextromethorphan—Dyspepsia—Dexamethasone—psoriasis	0.000247	0.00235	CcSEcCtD
Dextromethorphan—Dyspepsia—Betamethasone—psoriasis	0.000247	0.00235	CcSEcCtD
Dextromethorphan—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000246	0.00235	CcSEcCtD
Dextromethorphan—Dizziness—Cyclosporine—psoriasis	0.000244	0.00233	CcSEcCtD
Dextromethorphan—Gastrointestinal disorder—Betamethasone—psoriasis	0.000242	0.00231	CcSEcCtD
Dextromethorphan—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000242	0.00231	CcSEcCtD
Dextromethorphan—Hypersensitivity—Hydrocortisone—psoriasis	0.000242	0.0023	CcSEcCtD
Dextromethorphan—Fatigue—Dexamethasone—psoriasis	0.000241	0.0023	CcSEcCtD
Dextromethorphan—Fatigue—Betamethasone—psoriasis	0.000241	0.0023	CcSEcCtD
Dextromethorphan—Nervous system disorder—Prednisone—psoriasis	0.000239	0.00228	CcSEcCtD
Dextromethorphan—Dizziness—Mycophenolate mofetil—psoriasis	0.000238	0.00227	CcSEcCtD
Dextromethorphan—Asthenia—Hydrocortisone—psoriasis	0.000235	0.00224	CcSEcCtD
Dextromethorphan—Vomiting—Cyclosporine—psoriasis	0.000235	0.00224	CcSEcCtD
Dextromethorphan—Feeling abnormal—Dexamethasone—psoriasis	0.000231	0.0022	CcSEcCtD
Dextromethorphan—Feeling abnormal—Betamethasone—psoriasis	0.000231	0.0022	CcSEcCtD
Dextromethorphan—Gastrointestinal pain—Dexamethasone—psoriasis	0.000229	0.00219	CcSEcCtD
Dextromethorphan—Gastrointestinal pain—Betamethasone—psoriasis	0.000229	0.00219	CcSEcCtD
Dextromethorphan—Vomiting—Mycophenolate mofetil—psoriasis	0.000229	0.00218	CcSEcCtD
Dextromethorphan—Hypersensitivity—Triamcinolone—psoriasis	0.000227	0.00217	CcSEcCtD
Dextromethorphan—Diarrhoea—Hydrocortisone—psoriasis	0.000224	0.00214	CcSEcCtD
Dextromethorphan—Dizziness—Prednisolone—psoriasis	0.000222	0.00212	CcSEcCtD
Dextromethorphan—Asthenia—Triamcinolone—psoriasis	0.000221	0.00211	CcSEcCtD
Dextromethorphan—Abdominal pain—Dexamethasone—psoriasis	0.000221	0.00211	CcSEcCtD
Dextromethorphan—Abdominal pain—Betamethasone—psoriasis	0.000221	0.00211	CcSEcCtD
Dextromethorphan—Nausea—Cyclosporine—psoriasis	0.000219	0.00209	CcSEcCtD
Dextromethorphan—Dizziness—Hydrocortisone—psoriasis	0.000217	0.00207	CcSEcCtD
Dextromethorphan—Dyspepsia—Prednisone—psoriasis	0.000215	0.00205	CcSEcCtD
Dextromethorphan—Nausea—Mycophenolate mofetil—psoriasis	0.000214	0.00204	CcSEcCtD
Dextromethorphan—Fatigue—Prednisone—psoriasis	0.00021	0.00201	CcSEcCtD
Dextromethorphan—Constipation—Prednisone—psoriasis	0.000209	0.00199	CcSEcCtD
Dextromethorphan—Vomiting—Hydrocortisone—psoriasis	0.000208	0.00199	CcSEcCtD
Dextromethorphan—Confusional state—Methotrexate—psoriasis	0.000206	0.00196	CcSEcCtD
Dextromethorphan—Dizziness—Triamcinolone—psoriasis	0.000204	0.00195	CcSEcCtD
Dextromethorphan—Feeling abnormal—Prednisone—psoriasis	0.000201	0.00192	CcSEcCtD
Dextromethorphan—Asthenia—Dexamethasone—psoriasis	0.000201	0.00192	CcSEcCtD
Dextromethorphan—Asthenia—Betamethasone—psoriasis	0.000201	0.00192	CcSEcCtD
Dextromethorphan—Nervous system disorder—Methotrexate—psoriasis	0.0002	0.00191	CcSEcCtD
Dextromethorphan—Gastrointestinal pain—Prednisone—psoriasis	0.000199	0.0019	CcSEcCtD
Dextromethorphan—Nausea—Prednisolone—psoriasis	0.000199	0.0019	CcSEcCtD
Dextromethorphan—Vomiting—Triamcinolone—psoriasis	0.000196	0.00187	CcSEcCtD
Dextromethorphan—Nausea—Hydrocortisone—psoriasis	0.000195	0.00186	CcSEcCtD
Dextromethorphan—Abdominal pain—Prednisone—psoriasis	0.000193	0.00184	CcSEcCtD
Dextromethorphan—Diarrhoea—Dexamethasone—psoriasis	0.000192	0.00183	CcSEcCtD
Dextromethorphan—Diarrhoea—Betamethasone—psoriasis	0.000192	0.00183	CcSEcCtD
Dextromethorphan—Dizziness—Dexamethasone—psoriasis	0.000185	0.00177	CcSEcCtD
Dextromethorphan—Dizziness—Betamethasone—psoriasis	0.000185	0.00177	CcSEcCtD
Dextromethorphan—Nausea—Triamcinolone—psoriasis	0.000183	0.00175	CcSEcCtD
Dextromethorphan—Somnolence—Methotrexate—psoriasis	0.000181	0.00173	CcSEcCtD
Dextromethorphan—Hypersensitivity—Prednisone—psoriasis	0.00018	0.00171	CcSEcCtD
Dextromethorphan—Dyspepsia—Methotrexate—psoriasis	0.000179	0.00171	CcSEcCtD
Dextromethorphan—Vomiting—Dexamethasone—psoriasis	0.000178	0.0017	CcSEcCtD
Dextromethorphan—Vomiting—Betamethasone—psoriasis	0.000178	0.0017	CcSEcCtD
Dextromethorphan—Gastrointestinal disorder—Methotrexate—psoriasis	0.000176	0.00168	CcSEcCtD
Dextromethorphan—Fatigue—Methotrexate—psoriasis	0.000176	0.00168	CcSEcCtD
Dextromethorphan—Asthenia—Prednisone—psoriasis	0.000175	0.00167	CcSEcCtD
Dextromethorphan—Feeling abnormal—Methotrexate—psoriasis	0.000168	0.0016	CcSEcCtD
Dextromethorphan—Diarrhoea—Prednisone—psoriasis	0.000167	0.00159	CcSEcCtD
Dextromethorphan—Gastrointestinal pain—Methotrexate—psoriasis	0.000167	0.00159	CcSEcCtD
Dextromethorphan—Nausea—Dexamethasone—psoriasis	0.000166	0.00159	CcSEcCtD
Dextromethorphan—Nausea—Betamethasone—psoriasis	0.000166	0.00159	CcSEcCtD
Dextromethorphan—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000162	0.00266	CbGpPWpGaD
Dextromethorphan—Dizziness—Prednisone—psoriasis	0.000161	0.00154	CcSEcCtD
Dextromethorphan—Abdominal pain—Methotrexate—psoriasis	0.000161	0.00154	CcSEcCtD
Dextromethorphan—CHRNA4—SIDS Susceptibility Pathways—IL10—psoriasis	0.000161	0.00265	CbGpPWpGaD
Dextromethorphan—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000161	0.00265	CbGpPWpGaD
Dextromethorphan—CHRNB2—SIDS Susceptibility Pathways—CXCL8—psoriasis	0.000158	0.0026	CbGpPWpGaD
Dextromethorphan—OPRM1—G alpha (i) signalling events—CCL20—psoriasis	0.000155	0.00256	CbGpPWpGaD
Dextromethorphan—Vomiting—Prednisone—psoriasis	0.000155	0.00148	CcSEcCtD
Dextromethorphan—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000153	0.00252	CbGpPWpGaD
Dextromethorphan—SLC6A2—Monoamine Transport—TNF—psoriasis	0.000153	0.00252	CbGpPWpGaD
Dextromethorphan—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000152	0.0025	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000151	0.00249	CbGpPWpGaD
Dextromethorphan—Hypersensitivity—Methotrexate—psoriasis	0.00015	0.00143	CcSEcCtD
Dextromethorphan—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.00015	0.00247	CbGpPWpGaD
Dextromethorphan—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000149	0.00245	CbGpPWpGaD
Dextromethorphan—CHRNB2—SIDS Susceptibility Pathways—JUN—psoriasis	0.000147	0.00241	CbGpPWpGaD
Dextromethorphan—Asthenia—Methotrexate—psoriasis	0.000146	0.0014	CcSEcCtD
Dextromethorphan—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000146	0.0024	CbGpPWpGaD
Dextromethorphan—Nausea—Prednisone—psoriasis	0.000145	0.00138	CcSEcCtD
Dextromethorphan—CHRNB2—SIDS Susceptibility Pathways—NFKB1—psoriasis	0.000141	0.00232	CbGpPWpGaD
Dextromethorphan—Diarrhoea—Methotrexate—psoriasis	0.000139	0.00133	CcSEcCtD
Dextromethorphan—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000138	0.00228	CbGpPWpGaD
Dextromethorphan—OPRD1—GPCR downstream signaling—HCAR2—psoriasis	0.000138	0.00227	CbGpPWpGaD
Dextromethorphan—ABCB1—Allograft Rejection—IL13—psoriasis	0.000138	0.00226	CbGpPWpGaD
Dextromethorphan—SLC6A2—SLC-mediated transmembrane transport—CP—psoriasis	0.000136	0.00224	CbGpPWpGaD
Dextromethorphan—Dizziness—Methotrexate—psoriasis	0.000135	0.00129	CcSEcCtD
Dextromethorphan—SLC6A4—SIDS Susceptibility Pathways—IL10—psoriasis	0.000132	0.00217	CbGpPWpGaD
Dextromethorphan—Vomiting—Methotrexate—psoriasis	0.00013	0.00124	CcSEcCtD
Dextromethorphan—CHRNB2—SIDS Susceptibility Pathways—VEGFA—psoriasis	0.000128	0.00211	CbGpPWpGaD
Dextromethorphan—OPRD1—GPCR ligand binding—CCL20—psoriasis	0.000127	0.00209	CbGpPWpGaD
Dextromethorphan—OPRM1—TCR Signaling Pathway—NFKBIA—psoriasis	0.000127	0.00209	CbGpPWpGaD
Dextromethorphan—ABCB1—Allograft Rejection—IL17A—psoriasis	0.000127	0.00208	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling by GPCR—HCAR2—psoriasis	0.000125	0.00206	CbGpPWpGaD
Dextromethorphan—CHRNB4—SIDS Susceptibility Pathways—CXCL8—psoriasis	0.000124	0.00204	CbGpPWpGaD
Dextromethorphan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000124	0.00203	CbGpPWpGaD
Dextromethorphan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000121	0.00199	CbGpPWpGaD
Dextromethorphan—Nausea—Methotrexate—psoriasis	0.000121	0.00116	CcSEcCtD
Dextromethorphan—OPRK1—GPCR downstream signaling—HCAR2—psoriasis	0.000121	0.00199	CbGpPWpGaD
Dextromethorphan—CHRNB2—Circadian rythm related genes—JUN—psoriasis	0.00012	0.00197	CbGpPWpGaD
Dextromethorphan—ABCB1—Allograft Rejection—IL12B—psoriasis	0.000118	0.00194	CbGpPWpGaD
Dextromethorphan—CHRNB4—SIDS Susceptibility Pathways—JUN—psoriasis	0.000116	0.0019	CbGpPWpGaD
Dextromethorphan—ABCB1—Allograft Rejection—HLA-E—psoriasis	0.000115	0.00189	CbGpPWpGaD
Dextromethorphan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000113	0.00186	CbGpPWpGaD
Dextromethorphan—OPRK1—GPCR ligand binding—CCL20—psoriasis	0.000111	0.00183	CbGpPWpGaD
Dextromethorphan—CHRNB4—SIDS Susceptibility Pathways—NFKB1—psoriasis	0.000111	0.00183	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling by GPCR—HCAR2—psoriasis	0.00011	0.00181	CbGpPWpGaD
Dextromethorphan—CHRNB2—SIDS Susceptibility Pathways—TNF—psoriasis	0.00011	0.00181	CbGpPWpGaD
Dextromethorphan—CHRNA7—SIDS Susceptibility Pathways—CXCL8—psoriasis	0.000108	0.00177	CbGpPWpGaD
Dextromethorphan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000107	0.00176	CbGpPWpGaD
Dextromethorphan—OPRM1—GPCR downstream signaling—HCAR2—psoriasis	0.000102	0.00168	CbGpPWpGaD
Dextromethorphan—CHRNB4—SIDS Susceptibility Pathways—VEGFA—psoriasis	0.000101	0.00166	CbGpPWpGaD
Dextromethorphan—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.0001	0.00165	CbGpPWpGaD
Dextromethorphan—CHRNA7—SIDS Susceptibility Pathways—JUN—psoriasis	0.0001	0.00165	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	9.9e-05	0.00163	CbGpPWpGaD
Dextromethorphan—CHRNA7—SIDS Susceptibility Pathways—NFKB1—psoriasis	9.66e-05	0.00159	CbGpPWpGaD
Dextromethorphan—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	9.62e-05	0.00158	CbGpPWpGaD
Dextromethorphan—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	9.51e-05	0.00156	CbGpPWpGaD
Dextromethorphan—OPRM1—GPCR ligand binding—CCL20—psoriasis	9.41e-05	0.00155	CbGpPWpGaD
Dextromethorphan—OPRM1—TCR Signaling Pathway—CD4—psoriasis	9.39e-05	0.00154	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling by GPCR—HCAR2—psoriasis	9.29e-05	0.00153	CbGpPWpGaD
Dextromethorphan—CHRNB2—SIDS Susceptibility Pathways—IL6—psoriasis	8.87e-05	0.00146	CbGpPWpGaD
Dextromethorphan—SLC6A4—Circadian rythm related genes—LEP—psoriasis	8.86e-05	0.00146	CbGpPWpGaD
Dextromethorphan—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	8.85e-05	0.00146	CbGpPWpGaD
Dextromethorphan—CHRNA4—SIDS Susceptibility Pathways—CXCL8—psoriasis	8.8e-05	0.00145	CbGpPWpGaD
Dextromethorphan—CHRNA7—SIDS Susceptibility Pathways—VEGFA—psoriasis	8.76e-05	0.00144	CbGpPWpGaD
Dextromethorphan—CYP3A4—Tryptophan metabolism—CAT—psoriasis	8.66e-05	0.00142	CbGpPWpGaD
Dextromethorphan—CHRNB4—SIDS Susceptibility Pathways—TNF—psoriasis	8.65e-05	0.00142	CbGpPWpGaD
Dextromethorphan—ABCB1—Allograft Rejection—IL10—psoriasis	8.61e-05	0.00142	CbGpPWpGaD
Dextromethorphan—OPRM1—TCR Signaling Pathway—JUN—psoriasis	8.4e-05	0.00138	CbGpPWpGaD
Dextromethorphan—ABCB1—Allograft Rejection—IL4—psoriasis	8.37e-05	0.00138	CbGpPWpGaD
Dextromethorphan—SLC6A4—Circadian rythm related genes—NOS2—psoriasis	8.26e-05	0.00136	CbGpPWpGaD
Dextromethorphan—ABCB1—Allograft Rejection—HLA-B—psoriasis	8.19e-05	0.00135	CbGpPWpGaD
Dextromethorphan—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	8.18e-05	0.00135	CbGpPWpGaD
Dextromethorphan—CHRNA4—SIDS Susceptibility Pathways—JUN—psoriasis	8.18e-05	0.00134	CbGpPWpGaD
Dextromethorphan—OPRM1—TCR Signaling Pathway—NFKB1—psoriasis	8.09e-05	0.00133	CbGpPWpGaD
Dextromethorphan—CHRNB2—Circadian rythm related genes—TP53—psoriasis	7.91e-05	0.0013	CbGpPWpGaD
Dextromethorphan—CHRNA4—SIDS Susceptibility Pathways—NFKB1—psoriasis	7.87e-05	0.00129	CbGpPWpGaD
Dextromethorphan—SLC6A4—Circadian rythm related genes—PPARG—psoriasis	7.72e-05	0.00127	CbGpPWpGaD
Dextromethorphan—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	7.62e-05	0.00125	CbGpPWpGaD
Dextromethorphan—ABCB1—Allograft Rejection—HLA-A—psoriasis	7.59e-05	0.00125	CbGpPWpGaD
Dextromethorphan—CHRNA7—SIDS Susceptibility Pathways—TNF—psoriasis	7.51e-05	0.00124	CbGpPWpGaD
Dextromethorphan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.46e-05	0.00123	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—HCAR2—psoriasis	7.41e-05	0.00122	CbGpPWpGaD
Dextromethorphan—CHRNB2—Circadian rythm related genes—IL6—psoriasis	7.24e-05	0.00119	CbGpPWpGaD
Dextromethorphan—SLC6A4—SIDS Susceptibility Pathways—CXCL8—psoriasis	7.21e-05	0.00119	CbGpPWpGaD
Dextromethorphan—OPRD1—GPCR downstream signaling—CCL20—psoriasis	7.17e-05	0.00118	CbGpPWpGaD
Dextromethorphan—CHRNA4—SIDS Susceptibility Pathways—VEGFA—psoriasis	7.14e-05	0.00117	CbGpPWpGaD
Dextromethorphan—CHRNB4—SIDS Susceptibility Pathways—IL6—psoriasis	6.98e-05	0.00115	CbGpPWpGaD
Dextromethorphan—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	6.93e-05	0.00114	CbGpPWpGaD
Dextromethorphan—SLC6A2—Transmembrane transport of small molecules—CP—psoriasis	6.91e-05	0.00114	CbGpPWpGaD
Dextromethorphan—OPRD1—Peptide ligand-binding receptors—CXCL8—psoriasis	6.71e-05	0.0011	CbGpPWpGaD
Dextromethorphan—SLC6A4—SIDS Susceptibility Pathways—JUN—psoriasis	6.71e-05	0.0011	CbGpPWpGaD
Dextromethorphan—SLC6A2—Transmembrane transport of small molecules—CARM1—psoriasis	6.59e-05	0.00108	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling by GPCR—CCL20—psoriasis	6.51e-05	0.00107	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—HCAR2—psoriasis	6.5e-05	0.00107	CbGpPWpGaD
Dextromethorphan—SLC6A4—SIDS Susceptibility Pathways—NFKB1—psoriasis	6.45e-05	0.00106	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—TAGAP—psoriasis	6.42e-05	0.00106	CbGpPWpGaD
Dextromethorphan—OPRK1—GPCR downstream signaling—CCL20—psoriasis	6.29e-05	0.00103	CbGpPWpGaD
Dextromethorphan—CHRNA4—SIDS Susceptibility Pathways—TNF—psoriasis	6.12e-05	0.00101	CbGpPWpGaD
Dextromethorphan—CHRNA7—SIDS Susceptibility Pathways—IL6—psoriasis	6.06e-05	0.000997	CbGpPWpGaD
Dextromethorphan—CYP3A7—Metabolism—NDUFA5—psoriasis	6.01e-05	0.000988	CbGpPWpGaD
Dextromethorphan—OPRK1—Peptide ligand-binding receptors—CXCL8—psoriasis	5.88e-05	0.000968	CbGpPWpGaD
Dextromethorphan—SLC6A4—SIDS Susceptibility Pathways—VEGFA—psoriasis	5.86e-05	0.000964	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling by GPCR—CCL20—psoriasis	5.71e-05	0.000939	CbGpPWpGaD
Dextromethorphan—OPRD1—G alpha (i) signalling events—CXCL8—psoriasis	5.66e-05	0.000931	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—TAGAP—psoriasis	5.63e-05	0.000926	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—HCAR2—psoriasis	5.49e-05	0.000903	CbGpPWpGaD
Dextromethorphan—SLC6A4—Circadian rythm related genes—JUN—psoriasis	5.47e-05	0.0009	CbGpPWpGaD
Dextromethorphan—OPRM1—GPCR downstream signaling—CCL20—psoriasis	5.32e-05	0.000874	CbGpPWpGaD
Dextromethorphan—CYP3A7—Metabolism—CYP2S1—psoriasis	5.11e-05	0.00084	CbGpPWpGaD
Dextromethorphan—OPRM1—TCR Signaling Pathway—IL6—psoriasis	5.08e-05	0.000835	CbGpPWpGaD
Dextromethorphan—ABCB1—Allograft Rejection—IFNG—psoriasis	5.06e-05	0.000833	CbGpPWpGaD
Dextromethorphan—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	5.05e-05	0.000831	CbGpPWpGaD
Dextromethorphan—SLC6A4—SIDS Susceptibility Pathways—TNF—psoriasis	5.02e-05	0.000826	CbGpPWpGaD
Dextromethorphan—OPRM1—Peptide ligand-binding receptors—CXCL8—psoriasis	4.97e-05	0.000818	CbGpPWpGaD
Dextromethorphan—OPRK1—G alpha (i) signalling events—CXCL8—psoriasis	4.96e-05	0.000816	CbGpPWpGaD
Dextromethorphan—CHRNA4—SIDS Susceptibility Pathways—IL6—psoriasis	4.94e-05	0.000813	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling by GPCR—CCL20—psoriasis	4.83e-05	0.000794	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—TAGAP—psoriasis	4.76e-05	0.000783	CbGpPWpGaD
Dextromethorphan—ABCB1—Allograft Rejection—CXCL8—psoriasis	4.71e-05	0.000774	CbGpPWpGaD
Dextromethorphan—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	4.5e-05	0.00074	CbGpPWpGaD
Dextromethorphan—CYP2B6—Metabolism—NDUFA5—psoriasis	4.44e-05	0.00073	CbGpPWpGaD
Dextromethorphan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	4.41e-05	0.000726	CbGpPWpGaD
Dextromethorphan—CYP2E1—Metabolism—NDUFA5—psoriasis	4.35e-05	0.000715	CbGpPWpGaD
Dextromethorphan—CYP3A5—Metabolism—NDUFA5—psoriasis	4.34e-05	0.000714	CbGpPWpGaD
Dextromethorphan—OPRM1—G alpha (i) signalling events—CXCL8—psoriasis	4.19e-05	0.00069	CbGpPWpGaD
Dextromethorphan—SLC6A4—SIDS Susceptibility Pathways—IL6—psoriasis	4.05e-05	0.000666	CbGpPWpGaD
Dextromethorphan—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	3.95e-05	0.000649	CbGpPWpGaD
Dextromethorphan—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.88e-05	0.000638	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—CCL20—psoriasis	3.85e-05	0.000633	CbGpPWpGaD
Dextromethorphan—ABCB1—Allograft Rejection—VEGFA—psoriasis	3.82e-05	0.000629	CbGpPWpGaD
Dextromethorphan—CYP2B6—Metabolism—CYP2S1—psoriasis	3.78e-05	0.000621	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism—NDUFA5—psoriasis	3.76e-05	0.000618	CbGpPWpGaD
Dextromethorphan—CYP2E1—Metabolism—CYP2S1—psoriasis	3.7e-05	0.000608	CbGpPWpGaD
Dextromethorphan—CYP3A5—Metabolism—CYP2S1—psoriasis	3.69e-05	0.000607	CbGpPWpGaD
Dextromethorphan—SLC6A4—Circadian rythm related genes—TP53—psoriasis	3.61e-05	0.000594	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.51e-05	0.000577	CbGpPWpGaD
Dextromethorphan—OPRD1—GPCR ligand binding—CXCL8—psoriasis	3.43e-05	0.000564	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—CCL20—psoriasis	3.37e-05	0.000555	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—NDUFA5—psoriasis	3.36e-05	0.000552	CbGpPWpGaD
Dextromethorphan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	3.34e-05	0.000549	CbGpPWpGaD
Dextromethorphan—SLC6A4—Circadian rythm related genes—IL6—psoriasis	3.31e-05	0.000544	CbGpPWpGaD
Dextromethorphan—ABCB1—Allograft Rejection—TNF—psoriasis	3.28e-05	0.000539	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—NDUFA5—psoriasis	3.28e-05	0.000539	CbGpPWpGaD
Dextromethorphan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	3.26e-05	0.000536	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism—CYP2S1—psoriasis	3.2e-05	0.000526	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.13e-05	0.000515	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—NDUFA5—psoriasis	3.09e-05	0.000508	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—NDUFA5—psoriasis	3.06e-05	0.000503	CbGpPWpGaD
Dextromethorphan—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	3.04e-05	0.000501	CbGpPWpGaD
Dextromethorphan—OPRK1—GPCR ligand binding—CXCL8—psoriasis	3.01e-05	0.000494	CbGpPWpGaD
Dextromethorphan—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.9e-05	0.000478	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—CYP2S1—psoriasis	2.85e-05	0.000469	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.85e-05	0.000469	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—CCL20—psoriasis	2.85e-05	0.000469	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—CYP2S1—psoriasis	2.79e-05	0.000458	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—CYP2S1—psoriasis	2.62e-05	0.000432	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—CYP2S1—psoriasis	2.6e-05	0.000428	CbGpPWpGaD
Dextromethorphan—OPRM1—GPCR ligand binding—CXCL8—psoriasis	2.54e-05	0.000418	CbGpPWpGaD
Dextromethorphan—CYP3A7—Metabolism—CARM1—psoriasis	2.49e-05	0.00041	CbGpPWpGaD
Dextromethorphan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	2.16e-05	0.000355	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—SOCS1—psoriasis	2.12e-05	0.000348	CbGpPWpGaD
Dextromethorphan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	2.08e-05	0.000342	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling by GPCR—TYK2—psoriasis	2.02e-05	0.000332	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—NDUFA5—psoriasis	2.02e-05	0.000332	CbGpPWpGaD
Dextromethorphan—OPRD1—GPCR downstream signaling—CXCL8—psoriasis	1.94e-05	0.000319	CbGpPWpGaD
Dextromethorphan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.89e-05	0.00031	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—SOCS1—psoriasis	1.86e-05	0.000306	CbGpPWpGaD
Dextromethorphan—CYP2B6—Metabolism—CARM1—psoriasis	1.84e-05	0.000303	CbGpPWpGaD
Dextromethorphan—CYP2E1—Metabolism—CARM1—psoriasis	1.81e-05	0.000297	CbGpPWpGaD
Dextromethorphan—CYP3A5—Metabolism—CARM1—psoriasis	1.8e-05	0.000296	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling by GPCR—TYK2—psoriasis	1.77e-05	0.000291	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling by GPCR—CXCL8—psoriasis	1.76e-05	0.000289	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—CYP2S1—psoriasis	1.72e-05	0.000282	CbGpPWpGaD
Dextromethorphan—OPRK1—GPCR downstream signaling—CXCL8—psoriasis	1.7e-05	0.000279	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.68e-05	0.000276	CbGpPWpGaD
Dextromethorphan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.62e-05	0.000266	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—SOCS1—psoriasis	1.57e-05	0.000258	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—LEP—psoriasis	1.56e-05	0.000257	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—APOE—psoriasis	1.56e-05	0.000257	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism—CARM1—psoriasis	1.56e-05	0.000257	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling by GPCR—CXCL8—psoriasis	1.54e-05	0.000254	CbGpPWpGaD
Dextromethorphan—CYP3A7—Metabolism—CAT—psoriasis	1.53e-05	0.000252	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling by GPCR—TYK2—psoriasis	1.5e-05	0.000246	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.5e-05	0.000246	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.46e-05	0.00024	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—NFKBIA—psoriasis	1.46e-05	0.00024	CbGpPWpGaD
Dextromethorphan—OPRM1—GPCR downstream signaling—CXCL8—psoriasis	1.44e-05	0.000236	CbGpPWpGaD
Dextromethorphan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.43e-05	0.000234	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—CARM1—psoriasis	1.39e-05	0.000229	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—LEP—psoriasis	1.37e-05	0.000225	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—APOE—psoriasis	1.37e-05	0.000225	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.36e-05	0.000224	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—CARM1—psoriasis	1.36e-05	0.000224	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling by GPCR—CXCL8—psoriasis	1.3e-05	0.000214	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.3e-05	0.000214	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—CARM1—psoriasis	1.28e-05	0.000211	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—NFKBIA—psoriasis	1.28e-05	0.00021	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—CARM1—psoriasis	1.27e-05	0.000209	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—TYK2—psoriasis	1.19e-05	0.000196	CbGpPWpGaD
Dextromethorphan—CYP3A7—Metabolism—APOE—psoriasis	1.19e-05	0.000196	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.19e-05	0.000195	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—LEP—psoriasis	1.16e-05	0.000191	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—APOE—psoriasis	1.16e-05	0.000191	CbGpPWpGaD
Dextromethorphan—CYP2B6—Metabolism—CAT—psoriasis	1.13e-05	0.000187	CbGpPWpGaD
Dextromethorphan—CYP2E1—Metabolism—CAT—psoriasis	1.11e-05	0.000183	CbGpPWpGaD
Dextromethorphan—CYP3A5—Metabolism—CAT—psoriasis	1.11e-05	0.000182	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—NFKBIA—psoriasis	1.08e-05	0.000178	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—TYK2—psoriasis	1.05e-05	0.000172	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—CXCL8—psoriasis	1.04e-05	0.000171	CbGpPWpGaD
Dextromethorphan—CYP3A7—Metabolism—PPARG—psoriasis	1.04e-05	0.000171	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling by GPCR—IL6—psoriasis	9.88e-06	0.000162	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—JUN—psoriasis	9.66e-06	0.000159	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism—CAT—psoriasis	9.6e-06	0.000158	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—NFKB1—psoriasis	9.3e-06	0.000153	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—CXCL8—psoriasis	9.11e-06	0.00015	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—TYK2—psoriasis	8.84e-06	0.000145	CbGpPWpGaD
Dextromethorphan—CYP2B6—Metabolism—APOE—psoriasis	8.81e-06	0.000145	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling by GPCR—IL6—psoriasis	8.66e-06	0.000142	CbGpPWpGaD
Dextromethorphan—CYP2E1—Metabolism—APOE—psoriasis	8.63e-06	0.000142	CbGpPWpGaD
Dextromethorphan—CYP3A5—Metabolism—APOE—psoriasis	8.61e-06	0.000142	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—CAT—psoriasis	8.57e-06	0.000141	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—JUN—psoriasis	8.47e-06	0.000139	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—VEGFA—psoriasis	8.44e-06	0.000139	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—CARM1—psoriasis	8.38e-06	0.000138	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—CAT—psoriasis	8.37e-06	0.000138	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—STAT3—psoriasis	8.36e-06	0.000137	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—NFKB1—psoriasis	8.15e-06	0.000134	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—CAT—psoriasis	7.88e-06	0.00013	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—CAT—psoriasis	7.82e-06	0.000129	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—CXCL8—psoriasis	7.7e-06	0.000127	CbGpPWpGaD
Dextromethorphan—CYP2B6—Metabolism—PPARG—psoriasis	7.68e-06	0.000126	CbGpPWpGaD
Dextromethorphan—CYP2E1—Metabolism—PPARG—psoriasis	7.52e-06	0.000124	CbGpPWpGaD
Dextromethorphan—CYP3A5—Metabolism—PPARG—psoriasis	7.5e-06	0.000123	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism—APOE—psoriasis	7.46e-06	0.000123	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—VEGFA—psoriasis	7.4e-06	0.000122	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—STAT3—psoriasis	7.33e-06	0.000121	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling by GPCR—IL6—psoriasis	7.32e-06	0.00012	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—JUN—psoriasis	7.16e-06	0.000118	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—NFKB1—psoriasis	6.89e-06	0.000113	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—APOE—psoriasis	6.66e-06	0.00011	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—APOE—psoriasis	6.5e-06	0.000107	CbGpPWpGaD
Dextromethorphan—CYP2C8—Metabolism—PPARG—psoriasis	6.5e-06	0.000107	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—TP53—psoriasis	6.38e-06	0.000105	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—VEGFA—psoriasis	6.25e-06	0.000103	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—STAT3—psoriasis	6.19e-06	0.000102	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—APOE—psoriasis	6.13e-06	0.000101	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—APOE—psoriasis	6.07e-06	9.99e-05	CbGpPWpGaD
Dextromethorphan—OPRD1—Signaling Pathways—IL6—psoriasis	5.84e-06	9.6e-05	CbGpPWpGaD
Dextromethorphan—CYP2C19—Metabolism—PPARG—psoriasis	5.8e-06	9.54e-05	CbGpPWpGaD
Dextromethorphan—ABCB1—Metabolism—PPARG—psoriasis	5.66e-06	9.31e-05	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—TP53—psoriasis	5.59e-06	9.2e-05	CbGpPWpGaD
Dextromethorphan—CYP2D6—Metabolism—PPARG—psoriasis	5.34e-06	8.78e-05	CbGpPWpGaD
Dextromethorphan—CYP2C9—Metabolism—PPARG—psoriasis	5.29e-06	8.7e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—CAT—psoriasis	5.15e-06	8.48e-05	CbGpPWpGaD
Dextromethorphan—OPRK1—Signaling Pathways—IL6—psoriasis	5.12e-06	8.42e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—TP53—psoriasis	4.73e-06	7.77e-05	CbGpPWpGaD
Dextromethorphan—OPRM1—Signaling Pathways—IL6—psoriasis	4.33e-06	7.11e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—APOE—psoriasis	4.01e-06	6.59e-05	CbGpPWpGaD
Dextromethorphan—CYP3A4—Metabolism—PPARG—psoriasis	3.49e-06	5.74e-05	CbGpPWpGaD
